Skip to main content
. 2022 Jul 23;14(15):3595. doi: 10.3390/cancers14153595
ALDH 1aldehyde dehydrogenase isoform I
AMPK AMP-activated protein kinase
ASA acetylsalicylic acid or aspirin
CAF cancer-associated fibroblast
CI combination index
COX cyclooxygenase
CSC cancer stem cell
CTRL control
EBP elastin binding protein
ECM extracellular matrix
EGFR epidermal growth factor receptor
EMT epithelial-to-mesenchymal transition
GEM gemcitabine
GPCR G-protein coupled receptor
HuVEC human umbilical vein endothelial cell
IC50 half-maximal inhibitory concentration
IR insulin receptor
LC3-II light chain 3-II
MMP-9 matrix metalloproteinase-9
mTOR mammalian target of rapamycin
Neu-1 neuraminidase-1
NGF nerve growth factor
NSAID non-steroidal anti-inflammatory drug
OP oseltamivir phosphate
PDAC pancreatic ductal adenocarcinoma;
PI propidium iodide
PPCA cathepsin-binding protein
PS phosphatidylserine
RFU relative fluorescent units
RTK receptor tyrosine kinase
RWD relative wound density
TLR TOLL-like receptor
TME tumor microenvironment; Tmx; tamoxifen
TNBC triple-negative breast cancer